Senseonics Holdings, Inc. Common Stock Cash Flow Conversion Efficiency

Latest as of September 2025: -0.202x

Senseonics Holdings, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Senseonics Holdings, Inc. Common Stock (SENS) has a cash flow conversion efficiency ratio of -0.202x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.82 Million) by net assets ($78.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Senseonics Holdings, Inc. Common Stock (2013–2024)

Cash flow conversion efficiency of Senseonics Holdings, Inc. Common Stock from 2013 to 2024. This chart illustrates how Senseonics Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Senseonics Holdings, Inc. Common Stock stock quote for real-time trading data and today's change.

Senseonics Holdings, Inc. Common Stock Cash Flow Conversion Ratio Explained

Senseonics Holdings, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Senseonics Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Senseonics Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see market cap of Senseonics Holdings, Inc. Common Stock for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Federal-Mogul Goetze (India) Limited.
NSE:FMGOETZE
0.049x
Transcom Inc
TW:5222
0.028x
Nivika Fastigheter AB Series B
ST:NIVI-B
0.003x
Aurora Cannabis Inc
TO:ACB
-0.008x
Westwing Group AG
F:WEW
N/A
NEXCOM International Co Ltd
TWO:8234
0.017x
Jackson Acquisition Company II
NYSE:JACS
-0.001x
Intellian Technologies Inc
KQ:189300
-0.015x

Annual Cash Flow Conversion Efficiency for Senseonics Holdings, Inc. Common Stock (2013–2024)

The table below shows the annual cash flow conversion efficiency of Senseonics Holdings, Inc. Common Stock from 2013 to 2024. Review SENS financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-16.55 Million $-60.47 Million 3.652x +286.34%
2023-12-31 $35.80 Million $-70.16 Million -1.960x -107.61%
2022-12-31 $-2.58 Million $-66.31 Million 25.742x +8416.86%
2021-12-31 $-185.53 Million $-56.08 Million 0.302x -35.41%
2020-12-31 $-144.08 Million $-67.42 Million 0.468x -97.03%
2019-12-31 $-8.65 Million $-136.05 Million 15.730x +1334.89%
2018-12-31 $71.26 Million $-90.77 Million -1.274x +83.39%
2017-12-31 $7.27 Million $-55.74 Million -7.670x -198.40%
2016-12-31 $-4.88 Million $-38.02 Million 7.795x +196.83%
2015-12-31 $-9.70 Million $-25.46 Million 2.626x +207.84%
2014-12-31 $7.91 Million $-19.27 Million -2.435x +99.90%
2013-12-31 $7.08K $-17.17 Million -2424.375x --

About Senseonics Holdings, Inc. Common Stock

NYSE MKT:SENS USA Medical Devices
Market Cap
$259.04 Million
Market Cap Rank
#15261 Global
#3635 in USA
Share Price
$6.34
Change (1 day)
+2.92%
52-Week Range
$5.00 - $8.35
All Time High
$8.47
About

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more